🇺🇸 PCRX — Pacira BioSciences, Inc.

Salud Mantener
← Volver

Precio actual

36,40 USD

Máx. histórico

119,27

4270 días

Caída desde máximo

-69,48%

Rango 52 semanas

18,80 – 36,67

Variación hoy

+0,03%

Cierre anterior

36,39

Rango de hoy

36,38 – 36,45

Volumen hoy

2.420.374

Peor caída histórica

-90,19%

25/02/2015 → 09/08/2024

Aún sin recuperar

Volatilidad anualizada ⓘ

50,36%

Información
Nombre completo
Pacira BioSciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
825
PER ⓘ
104,00 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
33,57 USD (puede no estar actualizado)
Primera cotización
03/02/2011
Precio actualizado
hace 3 horas
Sobre la empresa

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
25/03/2021 67,41 70,08 66,59 69,66 +3,05% 5,18% 327.500
24/03/2021 70,01 70,62 67,30 67,60 -3,43% 4,74% 495.400
23/03/2021 69,47 70,38 68,48 70,00 -0,38% 2,73% 422.100
22/03/2021 71,40 71,40 68,94 70,27 +0,30% 3,45% 250.800
19/03/2021 70,47 71,20 68,54 70,06 +0,79% 3,77% 831.200
18/03/2021 69,79 71,36 68,36 69,51 -1,60% 4,30% 396.500
17/03/2021 70,63 71,11 69,06 70,64 -1,20% 2,90% 267.800
16/03/2021 72,86 73,00 70,53 71,50 -1,34% 3,39% 326.400
15/03/2021 72,96 74,76 72,05 72,47 -1,36% 3,71% 233.400
12/03/2021 72,20 73,85 71,51 73,47 +0,64% 3,24% 432.100
11/03/2021 71,96 73,34 71,23 73,00 +2,24% 2,93% 361.800
10/03/2021 70,60 72,56 70,60 71,40 +0,95% 2,78% 414.600
09/03/2021 71,88 72,20 69,64 70,73 +0,23% 3,56% 288.300
08/03/2021 69,34 70,93 68,06 70,57 +1,98% 4,14% 309.600
05/03/2021 68,14 69,40 64,81 69,20 +2,95% 6,74% 416.300
04/03/2021 68,80 70,37 66,63 67,22 -3,07% 5,44% 449.300
03/03/2021 71,38 71,56 69,18 69,35 -2,82% 3,33% 433.700
02/03/2021 72,38 73,18 70,64 71,36 -1,65% 3,51% 309.500
01/03/2021 75,41 75,81 71,24 72,56 -1,28% 6,06% 440.800
26/02/2021 75,05 75,74 71,89 73,50 -1,28% 5,13% 501.700
25/02/2021 78,54 80,00 73,29 74,45 -5,54% 8,54% 639.200
24/02/2021 76,14 79,64 75,79 78,82 +3,79% 5,06% 456.000
23/02/2021 75,27 76,35 72,30 75,94 -0,42% 5,38% 447.200
22/02/2021 75,26 76,99 73,19 76,26 +0,51% 5,05% 521.400
19/02/2021 74,62 76,17 73,90 75,87 +1,96% 3,04% 314.000
18/02/2021 74,15 75,48 73,24 74,41 +0,23% 3,02% 557.000
17/02/2021 73,32 76,25 73,03 74,24 -0,09% 4,39% 636.800
16/02/2021 77,67 77,84 73,76 74,31 -3,37% 5,25% 692.300
12/02/2021 78,25 79,98 76,63 76,90 -2,29% 4,28% 563.100
11/02/2021 76,42 79,20 76,19 78,70 +1,82% 3,94% 732.000